NEW YORK (GenomeWeb) –MDxHealth reported today a 63 percent increase in second quarter revenues driven primarily by accelerated sales of its ConfirmMDx prostate cancer test. 

For the three-month period ended June 30, the firm reported revenues of $6.3 million compared to $3.9 million in Q2 2015.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

A federal grand jury has indicted Elizabeth Holmes and Ramesh Balwani for alleged wire fraud in conjunction with their activities at Theranos.

Nature News reports that some developers are nervous about GitHub's acquisition by Microsoft.

A direct-to-consumer genetic testing company sent out used spit kits, CNBC reports.

In PLOS this week: comparison of commercial bisulfite kits, new method to predict essential proteins, and more